Evaluation of the clinical cutoff level of serum (1 → 3)-β-d-glucan in patients with connective tissue diseases complicated by deep fungal infections

Modern Rheumatology

Volumn 20, Issue 4, 2010, Pages 366-369

  Kato, Kenichi ^a   Onoda, Satoru ^a   Asano, Junichiro ^a   Fukaya, Shusaku ^a   Yoshida, Shunji ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

(1 3) D glucan; Connective tissue diseases; Fungal infections; Serological surrogate diagnostic marker

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-D-GLUCAN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; BLOOD; CANDIDIASIS; CONNECTIVE TISSUE DISEASE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ASPERGILLOSIS; BETA-GLUCANS; BIOLOGICAL MARKERS; CANDIDIASIS; CONNECTIVE TISSUE DISEASES; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 78349241124     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/s10165-010-0287-5     Document Type: Article

References (21)

1. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38: 161 – 89.
2. Kato K, Yoshida S, Fukaya S, Yoshida H, Mizutani A, Katayama M, et al. A study of infectious diseases in patients with connective tissue diseases. J Japanese Assoc Infect Dis. 2003; 77: 185.
3. Mori T, Ikemoto H, Matsumura M, Yoshida M, Inada K, Endo S, et al. Evaluation of plasma (1 - 3)-/3-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem. 1997; 35: 553 – 60.
4. Miyazaki T, Kohno S, Koga H, Kaku M, Mitsutake K, Maesaki S, et al. G test, a new direct method for diagnosis of Candida infection: comparison with assays for beta-glucan and mannnan antigen in a rabbit model of systemic candidiasis. J Clin Lab Anal. 1992; 6: 315 – 8.
5. Tamura H, Arimoto Y, Tanaka S, Yoshida M, Obayashi T, Kawai T. Automated kinetic assay for endotoxin and (1 - 3)-J3-D-glucan in human blood. Clin Chim Acta. 1994; 226: 109 – 12.
6. Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T, et al. Determination of plasma (1 - 3)-/3-D-glican: a new diagnostic aid to deep mycosis. J Med Vet Mycol. 1992; 30: 275 – 80.
7. Pauw B, Walsh T, Donnely JP, Ascioglu S, Bennett J, Bille J, et al. EORTC/BAMSG consensus revised definitions, draft VI. http://www.doctorfungus.org/lecture/EORTC_MSG_rev06.htm.
8. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985; 157: 611 – 4.
9. Logan PM, Primack SL, Miller RR, Milner NL. Invasive asper-gillosis of the airways; radiographic, CT and pathologic findings. Radiology. 1994; 19: 383 – 8.
10. Ascioglu S, Rex JH, Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international concensus. Clin Infect Dis. 2002; 34: 7 – 14.
11. Obayashi T, Yoshida M, Mori T, Tamura H, Aketagawa J, Tanaka S, et al. Plasma (1 - 3)-/3-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile epsodes. Lancet. 1995; 345: 17 – 20.
12. Tanaka H, Goto H, Sakaki S, Yoshinari S, Yoshizawa M, Shimazaki S, et al. Efficacy study of early presumptive therapy (EPT) for deep fungal infection. Nippon Ishinkin Gakkai Zasshi. 2004; 45: 203 – 8.
13. Imai K, Ashitani J, Imazu Y, Yanagi S, Sano S, Tokojima M, et al. Farmer's lung cases of a farmer and his son with high BAL fluid beta-D-glucan levels. Nihon Kokyuki Gakkai Zasshi. 2004; 42: 1024 – 9.
14. Hayashi M, Oku S, Mizobuchi S, Takeuchi M, Goto K, Matsumi M, et al. A case of fungal sepsis with high serum (1 - 3)-/3-D-glucan level. Nihon Shuchu Chiryo Igakukai Zasshi. 2003; 10: 187 – 91.
15. Moro H, Tsukada H, Ohara T, Susa R, Tanabe Y, Suzuki E. Clinical evaluation of performance of a new diagnostic method for deep mycosis by measuring /3-glucan concentration in the blood. Kansenshogaku Zasshi. 2003; 77: 219 – 26.
16. Solomkin JS, Flohr A, Simmons RL. Indications for therapy fungemia in postoperative patients. Arch Surg. 1982; 117: 1272 – 5.
17. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989; 149: 2349 – 53.
18. Dube MP, Heseeltine PNR, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rug-osa in a burn unit. Clin Infect Dis. 1994; 18: 77 – 82.
19. Halliday C, Wu QX, James G, Sorrell T. Development of a nested qualitative real-time per assay to detect Aspergillus species DNA in clinical specimens. J Clin Microbiol. 2005; 43: 5366 – 8.
20. Singh G, Imai J, Clemons KV, Stevens DA. Efficacy of caspo-fungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods. Antimicrob Agents Chemother. 2005; 49: 1369 – 76.
21. de Aguirre L, Hurst SF, Choi JS, Shin JH, Hinrikson HP, et al. Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol. 2004; 42: 3495 – 504.